CNOT6 Activators
CNOT6 activators are a class of chemical compounds that specifically engage with the CCR4-NOT transcription complex subunit 6 (CNOT6), which is an integral component of the CCR4-NOT complex, known to be one of the major cellular machinery elements involved in the regulation of mRNA turnover and degradation. CNOT6, along with its paralog CNOT6L, functions as a deadenylase, which is an enzyme that removes poly(A) tails from mRNA molecules, a critical step that marks the transcript for degradation and therefore regulates gene expression post-transcriptionally. The CCR4-NOT complex, with CNOT6 as a pivotal member, plays a crucial role in maintaining cellular homeostasis by balancing the synthesis and decay of mRNA transcripts, thus ensuring the proper control of gene expression.
Activators of CNOT6 are designed to modulate the activity of this enzyme, thereby influencing the mRNA degradation process. These molecules interact with CNOT6 in a manner that enhances its deadenylase activity, potentially leading to a more rapid turnover of mRNA transcripts. The precise mechanism by which CNOT6 activators exert their effects on the enzyme can vary depending on the molecular structure of the activator and the specific site of interaction on the CNOT6 protein. The activity of CNOT6 is intricately linked to numerous cellular pathways due to its fundamental role in mRNA decay, and the modulation of its activity by small molecule activators can have significant implications for the dynamic landscape of the transcriptome. As such, the study and development of CNOT6 activators are of considerable interest in the field of molecular biology and biochemistry for their ability to influence the regulation of gene expression at a post-transcriptional level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased levels of cAMP, which in turn enhances protein kinase A (PKA) activity. PKA can phosphorylate substrates that might interact with or modify the activity of CNOT6, thus possibly enhancing its RNA deadenylation activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) inhibits phosphodiesterases, leading to an increase in cAMP by preventing its breakdown. Elevated cAMP levels can stimulate PKA, which might phosphorylate proteins associated with the CNOT complex, potentially enhancing CNOT6 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) can modulate various signaling pathways including those involving PI3K/Akt. By influencing Akt signaling, EGCG can potentially affect downstream proteins that interact with or regulate CNOT6, possibly leading to enhanced CNOT6-mediated deadenylation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol can activate sirtuin 1 (SIRT1), which in turn can deacetylate and thus modify the activity of various transcription factors and other proteins. These modifications may affect proteins that regulate CNOT6's function, potentially enhancing its activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin influences the NF-kB pathway by inhibiting its activation. Since NF-kB can regulate the expression of various genes, this inhibition could lead to changes in the cellular environment that indirectly enhance the functional activity of CNOT6 through alteration of its regulatory proteins. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters the PI3K/Akt pathway. By inhibiting PI3K, downstream effects on protein interactions within this pathway could lead to changes in proteins that modulate CNOT6 activity, potentially enhancing its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which modulates various cellular processes. Inhibition of JNK can lead to altered transcription factor activity, potentially affecting the cellular levels or activity of proteins that interact with CNOT6, thereby indirectly enhancing its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. By inhibiting MEK, PD98059 can alter the phosphorylation state of proteins within this pathway, which may interact with or regulate CNOT6, potentially resulting in enhanced deadenylation activity of CNOT6. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK, affecting cytokine biosynthesis and the cellular stress response. This modulation of p38 MAPK activity could influence proteins that regulate or interact with CNOT6, potentially leading to an enhancement of CNOT6's activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is involved in cell growth and proliferation. By inhibiting mTOR, rapamycin could alter the phosphorylation state or availability of proteins that regulate CNOT6, potentially enhancing its RNA deadenylation function. | ||||||